Patents by Inventor David P. Carbone

David P. Carbone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeting of Notch3 Receptor Function for Cancer Therapy
    Publication number: 20110059096
    Abstract: The present invention involves the use of peptides from Notch3, and antibodies that recognize epitopes represented by those peptides, as anti-cancer agents. Methods of combination therapy using standard anti-cancer protocols in conjunction with Notch3 peptides and antibodies also are provided.
    Type: Application
    Filed: October 1, 2010
    Publication date: March 10, 2011
    Inventors: Thao P. Dang, David P. Carbone, Ray Mernaugh
  • Targeting of Notch3 receptor function for cancer therapy
    Patent number: 7807630
    Abstract: The present invention involves the use of peptides from Notch3, and antibodies that recognize epitopes represented by those peptides, as anti-cancer agents. Methods of combination therapy using standard anti-cancer protocols in conjunction with Notch3 peptides and antibodies also are provided.
    Type: Grant
    Filed: September 11, 2008
    Date of Patent: October 5, 2010
    Assignee: Vanderbilt University
    Inventors: Thao P. Dang, David P. Carbone, Ray Mernaugh
  • TARGETING OF NOTCH3 RECEPTOR FUNCTION FOR CANCER THERAPY
    Publication number: 20090092615
    Abstract: The present invention involves the use of peptides from Notch3, and antibodies that recognize epitopes represented by those peptides, as anti-cancer agents. Methods of combination therapy using standard anti-cancer protocols in conjunction with Notch3 peptides and antibodies also are provided.
    Type: Application
    Filed: September 11, 2008
    Publication date: April 9, 2009
    Inventors: THAO P. DANG, David P. Carbone, Ray Mernaugh